Genotoxicity Threshold

Genotoxicity threshold represents maximum acceptable level of potentially mutagenic contaminants balancing detection capability against theoretical cancer risk. Thresholds of toxicological concern employ structural alerts identifying potentially genotoxic chemical classes. Risk assessment assumes default mechanism-based tumour development at any DNA damage level; however, certain chemicals demonstrate threshold phenomena below which DNA adduct formation produces insufficient cancer risk.

Tiered assessment approaches conservatively assume non-threshold mechanisms unless substantial evidence demonstrates otherwise. Chemical-specific thresholds account for mechanism-of-action differences. Regulatory guidance establishes practical genotoxicity limits for pharmaceutical impurities. Impurities exceeding thresholds warrant toxicology evaluation demonstrating safety margins. Drug substance manufacturing process controls minimise genotoxic impurity formation. Regulatory submissions justify genotoxicity thresholds using scientific rationale. Emerging mechanistic toxicology refines threshold estimates improving risk assessment accuracy.